Adicet Bio, Inc (ACET) insider trading
Every open-market stock purchase and sale by Adicet Bio, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $6.6M over the last 12 months (2 buys).
- Insiders sold $675K over the last 12 months (1 sale).
- Last insider buy: Ra Capital Management L.p. (Insider), $543K, 7 months ago.
Last 12 months: insiders bought $6.6M (2 buys) and sold $675K (1 sale). Last close $7.98 on Aug 7, 2026.
Recent ACET insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Aug 5, 2026 | Lloyd Klickstein (C-suite exec) | Bought (not open market) | — |
| Jun 21, 2026 | Jeffrey Chodakewitz (Insider) | Bought (not open market) | — |
| Jun 21, 2026 | Katie Peng (Insider) | Bought (not open market) | — |
| Jun 21, 2026 | Steve Dubin (Insider) | Bought (not open market) | — |
| Jun 21, 2026 | Andrew Sinclair (Insider) | Bought (not open market) | — |
| Jun 21, 2026 | Michael Grissinger (Insider) | Bought (not open market) | — |
| Jun 21, 2026 | Lloyd Klickstein (Insider) | Bought (not open market) | — |
| Jun 19, 2026 | Chen Schor (CEO) | Bought (not open market) | — |
| Jun 19, 2026 | Blake Aftab (C-suite exec) | Bought (not open market) | — |
| Apr 27, 2026 | Ra Capital Management L.p. (Insider) | Bought (not open market) | $25 |
| Apr 8, 2026 | Orbimed Advisors LLC (10% owner) | Sold | $264K |
| Apr 8, 2026 | Orbimed Advisors LLC (10% owner) | Sold | $205K |
| Apr 7, 2026 | Orbimed Advisors LLC (10% owner) | Sold | $191K |
| Apr 7, 2026 | Orbimed Advisors LLC (10% owner) | Sold | $15.3K |
| Mar 25, 2026 | Blake Aftab (C-suite exec) | Bought (not open market) | — |
| Mar 25, 2026 | Chen Schor (CEO) | Bought (not open market) | — |
| Mar 25, 2026 | Julia D. Maltzman (C-suite exec) | Bought (not open market) | — |
| Mar 25, 2026 | Don Healey (CTO) | Bought (not open market) | — |
| Mar 25, 2026 | Brian Nicholas Harvey (CFO) | Bought (not open market) | — |
| Feb 20, 2026 | Ra Capital Management L.p. (Insider) | Bought | $543K |
| Feb 19, 2026 | Ra Capital Management L.p. (Insider) | Bought | $535K |
| Feb 18, 2026 | Ra Capital Management L.p. (Insider) | Bought | $525K |
| Jan 24, 2026 | Chen Schor (CEO) | Sold (not open market) | $14.8K |
| Jan 24, 2026 | Brian Nicholas Harvey (CFO) | Sold (not open market) | $4.6K |
| Jan 24, 2026 | Blake Aftab (C-suite exec) | Sold (not open market) | $4.5K |
Who's trading ACET
- Lloyd Klickstein, Insider: other filings, last Aug 5, 2026
- Jeffrey Chodakewitz, Insider: other filings, last Jun 21, 2026
- Steve Dubin, Insider: other filings, last Jun 21, 2026
- Andrew Sinclair, Insider: other filings, last Jun 21, 2026
- Katie Peng, Insider: other filings, last Jun 21, 2026
- Michael Grissinger, Insider: other filings, last Jun 21, 2026
- Blake Aftab, C-suite exec: other filings, last Jun 19, 2026
- Chen Schor, CEO: other filings, last Jun 19, 2026
- Ra Capital Management L.p., Insider: bought $1.6M (3 buys), last Apr 27, 2026
- Orbimed Advisors LLC, 10% owner: bought $5M (2 buys), sold $675K (4 sales), last Apr 8, 2026
- Julia D. Maltzman, C-suite exec: other filings, last Mar 25, 2026
- Don Healey, CTO: other filings, last Mar 25, 2026
- Brian Nicholas Harvey, CFO: other filings, last Mar 25, 2026
Get free alerts when an insider at Adicet Bio, Inc files a new trade →